Board Meetings for MANKIND
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MANKIND | Mankind Pharma Limited | 20 Sept 2024 | Fund Raising | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Companywill be held on September 20, 2024, inter-alia to consider and approve the raising of funds byway of issue of non-convertible debentures, commercial papers, other debt securities or any othersecurity or any combination thereof for an amount as may be decided by the Board. | |
| MANKIND | Mankind Pharma Limited | 31 Jul 2024 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 31-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 31 Jul 2024 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company will be held on Wednesday, July 31, 2024, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2024. | |
| MANKIND | Mankind Pharma Limited | 15 May 2024 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended March 31, 2024 and to evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. | |
| MANKIND | Mankind Pharma Limited | 15 May 2024 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Fund raising. | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 31 Jan 2024 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 31-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 31 Jan 2024 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company will be held on Wednesday, January 31, 2024, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on December 31, 2023.Further, in continuation of our earlier letter dated December 27, 2023 under subject Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's 'Code of Conduct for Prevention of Insider Trading', the trading window for trading in the securities of the Company shall remain closed till February 02, 2024.The above notice and details are also being uploaded on the website of the Company at www.mankindpharma.com. | |
| MANKIND | Mankind Pharma Limited | 31 Oct 2023 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 31-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 31 Oct 2023 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company will be held on Tuesday, October 31, 2023, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2023.Further, in continuation of our earlier letter dated September 27, 2023 under subject Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's 'Code of Conduct for Prevention of Insider Trading', the trading window for trading in the securities of the Company shall remain closed till November 02, 2023.The above notice and details are also being uploaded on the website of the Company at www.mankindpharma.com. | |
| MANKIND | Mankind Pharma Limited | 02 Aug 2023 | Mankind Pharma Limited has informed the Exchange about Board Meeting to be held on 02-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 02 Aug 2023 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company will be held on Wednesday, 2nd August 2023, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on 30th June 2023. | |
| MANKIND | Mankind Pharma Limited | 30 May 2023 | MANKIND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Board Meeting Intimation | |
| MANKIND | Mankind Pharma Limited | 30 May 2023 | Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
Showing page 2 of 2 (28 total items)